Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07592585 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

StatusRecruiting
PhasePhase 3
Started2026-05-12
View on ClinicalTrials.gov ↗

Amendment history

2026-07-03
Study Status, Contacts/Locations v2
Recruitment opened
Start dateestimated 2026-05-30→confirmed 2026-05-12
Study sitesdetails revised at 1 of 1 site
2026-05-18
Study Identification, Study Status v1
Study title-36 characters
Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
2026-05-12
Original filing
A multicenter, randomized, double-blind, vehicle controlled phase III clinical study to evaluate the efficacy and safety of VC005 in adults and adolescents with mild to moderate atopic dermatitis
Trial Details
NCT Number NCT07592585
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Atopic Dermatitis
Enrollment 360 participants
Start Date 2026-05-12
Primary Completion 2028-05-30 (estimated)
Study Completion 2028-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07